Subject: Human Growth Hormone (HGH) medications increase risks of colon, prostate and breast cancers

[Guest guest]

Human Growth Hormone (HGH) medications increase risks of colon, prostate and

breast cancers

 

Genetically Engineered Anti-Aging Medication (HGH) Poses Undisclosed Cancer

Risks,

Warns Samuel S. Epstein, M.D.

 

Use of the genetically engineered human growth hormone (HGH) for anti-aging

medication has become a major growth industry. Suppliers of HGH, including

those offering mail order prescriptions, are proliferating on websites and the

Internet. The Chicago-based seven-year-old American Academy of Anti-Aging

Medicine, with over 8000 members, promotes injectable HGH in programs claiming

to stop or even reverse aging, including decreasing body fat, and increasing

muscle mass and bone density. However, practitioners of this burgeoning

" health " industry are either ignorant of or suppress well-documented

information on the grave cancer risks of HGH medication.

 

HGH induces growth promoting and other effects by stimulating the liver to

increase production of the natural Insulin-like Growth Factor-1 (IGF-1) whose

blood levels normally decline with advancing age. However, there are numerous

publications in prestigious peer reviewed scientific journals showing that

elevated IGF-1 levels are strongly associated with major excess risks of colon,

prostate, and breast cancers; even minor elevations are associated with up to

7-fold increased risks of breast cancer, risks almost as high as those in women

carrying genes (BRCA1 and BRCA2) with the strongest hereditary predisposition.

Additionally, IGF-1 inhibits the programmed self-destruction (apoptosis) of

cancer cells, thus stimulating the growth and invasiveness of small,

undiagnosed cancers, besides increasing the resistance of cancers to

chemotherapy. For these reasons, anti-aging HGH medication, compounded by

failure to explicitly disclose its grave risks, constitutes medical

malpractice.

 

Learn more about IGF-1

There are also growing concerns on possible risks from the use of HGH

nutritional supplements, including oral sprays. It should, however, be

recognized that HGH absorption from the mouth and gut is unlikely to be

significant, in striking contrast to complete absorption from injectable

medication. Nevertheless, nutritional HGH supplements should be phased out

until it can be shown that they do not elevate blood IGF-1 levels.

 

HGH medication should only be used by qualified endocrinologists for highly

restricted medical disorders, such as dwarfism due to pituitary gland

deficiency, as approved by the FDA in 1985; anti-aging medication has never

received such approval.

 

Source: Cancer Prevention Coalition Press Release – March 14, 2000

 

CONTACT:

Samuel S. Epstein, M.D. Chairman, Cancer Prevention Coalition c/o University

of Illinois at Chicago School of Public Health, M/C 922 2121 W. Taylor Street

Chicago, IL 60612

312-996-2297 epst-

 

http://www.preventcancer.com/avoidable/breast_cancer/hgh_risks.htm